Radiation Oncology Market By Product, By Application - Global Industry Analysis & Forecast to 2027

Published On : October 2018 Pages : 180 Category: Medical Devices Report Code : HC101489

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

Radiation Oncology Market By Product (Brachytherapy, External Beam Radiation Therapy, Systemic Beam Radiation Therapy and Others) By Application (Cervical Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Brain Cancer, Head & Neck Cancer and Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Radiation Oncology Market has observed major development in the recent years and is anticipated to grow tremendously during the forecast period. Radiation oncology is a medicinal specialty that makes use of high vitality radiation, for example, X-rays, electrons for cancer treatment, gamma rays and protons. These high energy ionizing radiation damage nucleic acids through the development of responsive oxygen species and free radicals directly or indirectly. Radiation treatment can be utilized as a part of mix with surgery, immunotherapy, and chemotherapy. As per the estimation of National Cancer Institute, in the US, around 1.6 million new instances of growth are analyzed, and 595,690 individuals have passed on because of tumor in 2017.

Drivers and Restraints

The radiation oncology market is developing because of expanding prevalence of cancer universally, expanding aged population, and progressions in technology. The high expense of instrument and treatment, reactions, and shortage of skilled specialists in developing nations are few of the components hampering the market development. The markets in developing nations are anticipated to develop quickly amid the figure time frame because of expanding social insurance spending, developing patient pool, and expanding medicinal services awareness among people in general. Growing cases of cancer and increasing demand for non-invasive procedures in developing countries are anticipated to boost the development of the radiation oncology market in the upcoming years.

Regional Outlook and Trend Analysis

North America drove worldwide market for radiation oncology with more than XX.X% share in 2017. This strength can be ascribed to cutting edge medicinal services foundation, high social insurance use, and more noteworthy research and development endeavors. Besides, Asia Pacific is anticipated to witness a lucrative CAGR over the estimate time frame. Ascend in aging populace, urbanization, and expanding wealth in low-and center wage nations like India and China have prompted provincial market development.

Competitive Insights

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Accuray Incorporated
Nordion (Canada) Inc
IsoRay, Mallinckrodt
Varian Medical Systems
Mevion Medical Systems
Elekta
C. R. Bard
Ion Beam Applications

The Radiation Oncology Market is segmented as follows-

By Product:

Brachytherapy
Systemic Beam Radiation Therapy
External Beam Radiation Therapy
- Compact Advanced Radiotherapy Systems
- Electron-Emitting High-Energy Linear Accelerators
Others

By Application:

Cervical Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Brain Cancer
Head & Neck Cancer
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

· Radiation Oncology Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

· Brachytherapy

· Systemic Beam Radiation Therapy

· External Beam Radiation Therapy

§ Compact Advanced Radiotherapy Systems

§ Electron-Emitting High-Energy Linear Accelerators

· Others

· Radiation Oncology Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

· Cervical Cancer

· Prostate Cancer

· Breast Cancer

· Lung Cancer

· Brain Cancer

· Head & Neck Cancer

· Others

· Radiation Oncology Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

· North America

§ North America Radiation Oncology Market, By Country

o U.S. Radiation Oncology Market

o Canada Radiation Oncology Market

o Mexico Radiation Oncology Market

· Europe

§ Europe Radiation Oncology Market, By Country

o Germany Radiation Oncology Market

o UK Radiation Oncology Market

o France Radiation Oncology Market

o Russia Radiation Oncology Market

o Italy Radiation Oncology Market

o Rest of Europe Radiation Oncology Market

· Asia-Pacific

§ Asia-Pacific Radiation Oncology Market, By Country

o China Radiation Oncology Market

o Japan Radiation Oncology Market

o South Korea Radiation Oncology Market

o India Radiation Oncology Market

o Southeast Asia Radiation Oncology Market

o Rest of Asia-Pacific Radiation Oncology Market

· South America

§ South America Radiation Oncology Market

o Brazil Radiation Oncology Market

o Argentina Radiation Oncology Market

o Columbia Radiation Oncology Market

o Rest of South America Radiation Oncology Market

· Middle East and Africa

§ Middle East and Africa Radiation Oncology Market

o Saudi Arabia Radiation Oncology Market

o UAE Radiation Oncology Market

o Egypt Radiation Oncology Market

o Nigeria Radiation Oncology Market

o South Africa Radiation Oncology Market

o Rest of MEA Radiation Oncology Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market States and Outlook (2017-2027)

4.1.2. Canada Market States and Outlook (2017-2027)

4.1.3. Mexico Market States and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market States and Outlook (2017-2027)

4.2.2. France Market States and Outlook (2017-2027)

4.2.3. UK Market States and Outlook (2017-2027)

4.2.4. Russia Market States and Outlook (2017-2027)

4.2.5. Italy Market States and Outlook (2017-2027)

4.2.6. Rest of Europe Market States and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market States and Outlook (2017-2027)

4.3.2. Japan Market States and Outlook (2017-2027)

4.3.3. Korea Market States and Outlook (2017-2027)

4.3.4. India Market States and Outlook (2017-2027)

4.3.5. Southeast Asia Market States and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market States and Outlook (2017-2027)

4.4.2. Argentina Market States and Outlook (2017-2027)

4.4.3. Columbia Market States and Outlook (2017-2027)

4.4.4. Rest of South America Market States and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market States and Outlook (2017-2027)

4.5.2. United Arab Emirates Market States and Outlook (2017-2027)

4.5.3. Egypt Market States and Outlook (2017-2027)

4.5.4. Nigeria Market States and Outlook (2017-2027)

4.5.5. South Africa Market States and Outlook (2017-2027)

4.5.6. Turkey Market States and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)

5. Tissue Diagnostics Market, By Product

5.1. Introduction

5.2. Global Tissue Diagnostics Revenue and Market Share by Product (2017-2027)

5.2.1. Global Tissue Diagnostics Revenue and Revenue Share by Product (2017-2027)

5.3. Brachytherapy

5.3.1. Global Brachytherapy Revenue and Growth Rate (2017-2027)

5.4. External Beam Radiation Therapy

5.4.1. Global External Beam Radiation Therapy Revenue and Growth Rate (2017-2027)

5.4.2. Global External Beam Radiation Therapy By Type

5.4.3. Compact Advanced Radiotherapy Systems

5.4.3.1. Global Compact Advanced Radiotherapy Systems Revenue and Growth Rate (2017-2027)

5.4.4. Electron-Emitting High-Energy Linear Accelerators

5.4.4.1. Global Electron-Emitting High-Energy Linear Accelerators Revenue and Growth Rate (2017-2027)

5.5. Systemic Beam Radiation Therapy

5.5.1. Global Systemic Beam Radiation Therapy Revenue and Growth Rate (2017-2027)

5.6. Others

5.6.1. Global Others Revenue and Growth Rate (2017-2027)

6. Tissue Diagnostics Market, By Application

6.1. Introduction

6.2. Global Tissue Diagnostics Revenue and Market Share by Application (2017-2027)

6.2.1. Global Tissue Diagnostics Revenue and Revenue Share by Application (2017-2027)

6.3. Cervical Cancer

6.3.1. Global Cervical Cancer Revenue and Growth Rate (2017-2027)

6.4. Prostate Cancer

6.4.1. Global Prostate Cancer Revenue and Growth Rate (2017-2027)

6.5. Breast Cancer

6.5.1. Global Breast Cancer Revenue and Growth Rate (2017-2027)

6.6. Lung Cancer

6.6.1. Global Lung Cancer Revenue and Growth Rate (2017-2027)

6.7. Brain Cancer

6.7.1. Global Brain Cancer Revenue and Growth Rate (2017-2027)

6.8. Head & Neck Cancer

6.8.1. Global Head & Neck Cancer Revenue and Growth Rate (2017-2027)

6.9. Others

6.9.1. Global Others Revenue and Growth Rate (2017-2027)

7. Tissue Diagnostics Market, By Region

7.1. Introduction

7.2. Global Tissue Diagnostics Revenue and Market Share by Regions

7.2.1. Global Tissue Diagnostics Revenue by Regions (2017-2027)

7.3. North America Tissue Diagnostics by Countries

7.3.1. North America Tissue Diagnostics Revenue and Growth Rate (2017-2027)

7.3.2. North America Tissue Diagnostics Revenue (Million USD) by Countries (2017-2027)

7.3.3. United States

7.3.3.1. United States Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4. Canada

7.3.4.1. Canada Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5. Mexico

7.3.5.1. Mexico Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4. Europe Tissue Diagnostics by Countries

7.4.1. Europe Tissue Diagnostics Revenue and Growth Rate (2017-2027)

7.4.2. Europe Tissue Diagnostics Revenue (Million USD) by Countries (2017-2027)

7.4.3. Germany

7.4.3.1. Germany Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4. France

7.4.4.1. France Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5. UK

7.4.5.1. UK Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6. Russia

7.4.6.1. Russia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7. Italy

7.4.7.1. Italy Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8. Rest of Europe

7.4.8.1. Rest of Europe Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5. Asia-Pacific Tissue Diagnostics by Countries

7.5.1. Asia-Pacific Tissue Diagnostics Revenue and Growth Rate (2017-2027)

7.5.2. Asia-Pacific Tissue Diagnostics Revenue (Million USD) by Countries (2017-2027)

7.5.3. China

7.5.3.1. China Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4. Japan

7.5.4.1. Japan Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5. Korea

7.5.5.1. Korea Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6. India

7.5.6.1. India Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7. Southeast Asia

7.5.7.1. Southeast Asia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8. Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6. South America Tissue Diagnostics by Countries

7.6.1. South America Tissue Diagnostics Revenue and Growth Rate (2017-2027)

7.6.2. South America Tissue Diagnostics Revenue (Million USD) by Countries (2017-2027)

7.6.3. Brazil

7.6.3.1. Brazil Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4. Argentina

7.6.4.1. Argentina Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5. Columbia

7.6.5.1. Columbia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6. Rest of South America

7.6.6.1. Rest of South America Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7. Middle East and Africa Tissue Diagnostics by Countries

7.7.1. Middle East and Africa Tissue Diagnostics Revenue and Growth Rate (2017-2027)

7.7.2. Middle East and Africa Tissue Diagnostics Revenue (Million USD) by Countries (2017-2027)

7.7.3. Saudi Arabia

7.7.3.1. Saudi Arabia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4. United Arab Emirates

7.7.4.1. United Arab Emirates Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5. Egypt

7.7.5.1. Egypt Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6. Nigeria

7.7.6.1. Nigeria Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7. South Africa

7.7.7.1. South Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8. Turkey

7.7.8.1. Turkey Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9. Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

8. Company Profiles

8.1. Accuray Incorporated

8.1.1. Business Overview

8.1.2. Service Portfolio

8.1.3. Strategic Developments

8.1.4. Revenue and Market Share

8.2. Nordion (Canada) Inc

8.2.1. Business Overview

8.2.2. Service Portfolio

8.2.3. Strategic Developments

8.2.4. Revenue and Market Share

8.3. IsoRay

8.3.1. Business Overview

8.3.2. Service Portfolio

8.3.3. Strategic Developments

8.3.4. Revenue and Market Share

8.4. Mallinckrodt

8.4.1. Business Overview

8.4.2. Service Portfolio

8.4.3. Strategic Developments

8.4.4. Revenue and Market Share

8.5. Varian Medical Systems

8.5.1. Business Overview

8.5.2. Service Portfolio

8.5.3. Strategic Developments

8.5.4. Revenue and Market Share

8.6. Mevion Medical Systems

8.6.1. Business Overview

8.6.2. Service Portfolio

8.6.3. Strategic Developments

8.6.4. Revenue and Market Share

8.7. Elekta

8.7.1. Business Overview

8.7.2. Service Portfolio

8.7.3. Strategic Developments

8.7.4. Revenue and Market Share

8.8. C. R. Bard

8.8.1. Business Overview

8.8.2. Service Portfolio

8.8.3. Strategic Developments

8.8.4. Revenue and Market Share

8.9. Ion Beam Applications

8.9.1. Business Overview

8.9.2. Service Portfolio

8.9.3. Strategic Developments

8.9.4. Revenue and Market Share

9. Global Tissue Diagnostics Market Competition, by Manufacturer

9.1. Global Tissue Diagnostics Revenue and Market Share by Manufacturer (2017-2017)

9.2. Global Tissue Diagnostics Price By Region (2017-2017)

9.3. Top 5 Tissue Diagnostics Manufacturer Market Share

9.4. Market Competition Trend

10. Tissue Diagnostics Market Forecast (2017-2027)

10.1. Global Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Tissue Diagnostics Market Forecast by Regions (2017-2027)

10.2.1. North America Tissue Diagnostics Market Forecast (2017-2027)

10.2.1.1. United States Tissue Diagnostics Market Forecast (2017-2027)

10.2.1.2. Canada Tissue Diagnostics Market Forecast (2017-2027)

10.2.1.3. Mexico Tissue Diagnostics Market Forecast (2017-2027)

10.2.2. Europe Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.1. Germany Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.2. France Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.3. UK Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.4. Russia Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.5. Italy Tissue Diagnostics Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Tissue Diagnostics Market Forecast (2017-2027)

10.2.3. Asia-Pacific Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.1. China Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.2. Japan Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.3. Korea Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.4. India Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Tissue Diagnostics Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Tissue Diagnostics Market Forecast (2017-2027)

10.2.4. South America Tissue Diagnostics Market Forecast (2017-2027)

10.2.4.1. Brazil Tissue Diagnostics Market Forecast (2017-2027)

10.2.4.2. Argentina Tissue Diagnostics Market Forecast (2017-2027)

10.2.4.3. Columbia Tissue Diagnostics Market Forecast (2017-2027)

10.2.4.4. Rest of South America Tissue Diagnostics Market Forecast (2017-2027)

10.2.5. Middle East and Africa Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.3. Egypt Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.4. Nigeria Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.5. South Africa Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.6. Turkey Tissue Diagnostics Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Tissue Diagnostics Market Forecast (2017-2027)

10.3. Tissue Diagnostics Market Forecast by Product (2017-2027)

10.3.1. Tissue Diagnostics Forecast by Product (2017-2027)

10.3.2. Tissue Diagnostics Market Share Forecast by Product (2017-2027)

10.4. Tissue Diagnostics Market Forecast by Application (2017-2027)

10.4.1. Tissue Diagnostics Forecast by Application (2017-2027)

10.4.2. Tissue Diagnostics Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Tissue Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Tissue Diagnostics Revenue and Revenue Share by Product (2017-2018)
Figure Global Brachytherapy Revenue and Growth Rate (2017-2018)
Figure Global External Beam Radiation Therapy Revenue and Growth Rate (2017-2018)
Figure Global Systemic Beam Radiation Therapy Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Tissue Diagnostics Revenue and Revenue Share by Application (2017-2018)
Figure Global Cervical Cancer Revenue and Growth Rate (2017-2018)
Figure Global Prostate Cancer Revenue and Growth Rate (2017-2018)
Figure Global Breast Cancer Revenue and Growth Rate (2017-2018)
Figure Global Lung Cancer Revenue and Growth Rate (2017-2018)
Figure Global Brain Cancer Revenue and Growth Rate (2017-2018)
Figure Global Head & Neck Cancer Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Tissue Diagnostics Revenue by Regions (2017-2018)
Figure North America Tissue Diagnostics Growth Rate (2017-2018)
Figure North America Tissue Diagnostics Revenue and Growth Rate (2017-2018)
Figure North America Tissue Diagnostics by Countries (2017-2018)
Figure North America Tissue Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure United States Tissue Diagnostics Growth Rate (2017-2018)
Figure United States Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Tissue Diagnostics Growth Rate (2017-2018)
Figure Canada Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Tissue Diagnostics Growth Rate (2017-2018)
Figure Mexico Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Tissue Diagnostics Growth Rate (2017-2018)
Figure Europe Tissue Diagnostics Revenue and Growth Rate (2017-2018)
Figure Europe Tissue Diagnostics by Countries (2017-2018)
Figure Europe Tissue Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Tissue Diagnostics Growth Rate (2017-2018)
Figure Germany Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Tissue Diagnostics Growth Rate (2017-2018)
Figure France Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Tissue Diagnostics Growth Rate (2017-2018)
Figure UK Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Tissue Diagnostics Growth Rate (2017-2018)
Figure Russia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Tissue Diagnostics Growth Rate (2017-2018)
Figure Italy Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Tissue Diagnostics Growth Rate (2017-2018)
Figure Rest of Europe Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Tissue Diagnostics Growth Rate (2017-2018)
Figure Asia-Pacific Tissue Diagnostics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Tissue Diagnostics by Countries (2017-2018)
Figure Asia-Pacific Tissue Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure China Tissue Diagnostics Growth Rate (2017-2018)
Figure China Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Tissue Diagnostics Growth Rate (2017-2018)
Figure Japan Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Tissue Diagnostics Growth Rate (2017-2018)
Figure Korea Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Tissue Diagnostics Growth Rate (2017-2018)
Figure India Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Tissue Diagnostics Growth Rate (2017-2018)
Figure Southeast Asia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tissue Diagnostics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Tissue Diagnostics Growth Rate (2017-2018)
Figure South America Tissue Diagnostics Revenue and Growth Rate (2017-2018)
Figure South America Tissue Diagnostics by Countries (2017-2018)
Figure South America Tissue Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Tissue Diagnostics Growth Rate (2017-2018)
Figure Brazil Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Tissue Diagnostics Growth Rate (2017-2018)
Figure Argentina Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Tissue Diagnostics Growth Rate (2017-2018)
Figure Columbia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Tissue Diagnostics Growth Rate (2017-2018)
Figure Rest of South America Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Tissue Diagnostics Growth Rate (2017-2018)
Figure Middle East and Africa Tissue Diagnostics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Tissue Diagnostics by Countries (2017-2018)
Figure Middle East and Africa Tissue Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Tissue Diagnostics Growth Rate (2017-2018)
Figure Saudi Arabia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Tissue Diagnostics Growth Rate (2017-2018)
Figure United Arab Emirates Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Tissue Diagnostics Growth Rate (2017-2018)
Figure Egypt Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Tissue Diagnostics Growth Rate (2017-2018)
Figure Nigeria Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Tissue Diagnostics Growth Rate (2017-2018)
Figure South Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Tissue Diagnostics Growth Rate (2017-2018)
Figure Turkey Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tissue Diagnostics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Accuray Incorporated Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Nordion (Canada) Inc Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IsoRay Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mallinckrodt Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Varian Medical Systems Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mevion Medical Systems Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Elekta Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table C. R. Bard Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ion Beam Applications Tissue Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Tissue Diagnostics Market Share by Manufacturer
Figure Global Tissue Diagnostics Revenue and Market Share by Manufacturer
Table Global Tissue Diagnostics Price by Region (2017-2017)
Figure Top 5 Tissue Diagnostics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Tissue Diagnostics Market Forecast by Regions (2018-2025)
Figure North America Tissue Diagnostics Market Forecast (2018-2025)
Figure United States Tissue Diagnostics Market Forecast (2018-2025)
Figure Canada Tissue Diagnostics Market Forecast (2018-2025)
Figure Mexico Tissue Diagnostics Market Forecast (2018-2025)
Figure Europe Tissue Diagnostics Market Forecast (2018-2025)
Figure Germany Tissue Diagnostics Market Forecast (2018-2025)
Figure France Tissue Diagnostics Market Forecast (2018-2025)
Figure UK Tissue Diagnostics Market Forecast (2018-2025)
Figure Russia Tissue Diagnostics Market Forecast (2018-2025)
Figure Italy Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Europe Tissue Diagnostics Market Forecast (2018-2025)
Figure Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)
Figure China Tissue Diagnostics Market Forecast (2018-2025)
Figure Japan Tissue Diagnostics Market Forecast (2018-2025)
Figure Korea Tissue Diagnostics Market Forecast (2018-2025)
Figure India Tissue Diagnostics Market Forecast (2018-2025)
Figure Southeast Asia Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)
Figure South America Tissue Diagnostics Market Forecast (2018-2025)
Figure Brazil Tissue Diagnostics Market Forecast (2018-2025)
Figure Argentina Tissue Diagnostics Market Forecast (2018-2025)
Figure Columbia Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of South America Tissue Diagnostics Market Forecast (2018-2025)
Figure Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Saudi Arabia Tissue Diagnostics Market Forecast (2018-2025)
Figure United Arab Emirates Tissue Diagnostics Market Forecast (2018-2025)
Figure Egypt Tissue Diagnostics Market Forecast (2018-2025)
Figure Nigeria Tissue Diagnostics Market Forecast (2018-2025)
Figure South Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Turkey Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Global Tissue Diagnostics Forecast by Product (2018-2025)
Figure Global Tissue Diagnostics Market Share Forecast by Product (2018-2025)
Figure Global Tissue Diagnostics Forecast by Product (2018-2025)
Figure Global Tissue Diagnostics Forecast by Application (2018-2025)
Figure Global Tissue Diagnostics Market Share Forecast by Application (2018-2025)
Figure Global Tissue Diagnostics Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment